David Bakal (Pre-Doctoral; Rio de Janeiro, Brazil) is a student at UCLA Geffen School of Medicine and a Pre-Doctoral Fellow at the Rio de Janeiro site. David is currently exploring the association of HIV infection and antiretroviral therapy with obesity in Brazil.
Research Area:
Longitudinal analysis of HIV infection, antiretroviral therapy, and obesity in Brazil.
Publications:
Bakal et al. HIV disease severity and integrase inhibitor use are drivers of obesity following antiretroviral therapy initiation. Manuscript under review.
Applications for the 2026-27 Fellowship class are now being accepted and will be reviewed on a rolling basis.